IBD | No IBD | p value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Age | |||||
< 60 years | 4 | 13% | 860 | 20% | 0.58 |
60–70 years | 15 | 48% | 1840 | 44% | |
> 70 years | 12 | 39% | 1514 | 36% | |
ECOG | |||||
0 | 18 | 58% | |||
1 | 2 | 7% | |||
No score | 11 | 35% | |||
PSA (mg/mL) | |||||
< 10 | 24 | 77% | 3281 | 78% | 0.09 |
10–20 | 3 | 10% | 725 | 17% | |
> 20 | 4 | 13% | 208 | 5% | |
AJCC 8-edition stage | |||||
T1 | 24 | 77% | 3436 | 82% | 0.65 |
T2 | 7 | 23% | 733 | 17% | |
T3–T4 | 0 | 0% | 45 | 1% | |
Grade group | |||||
1 | 9 | 29% | 1314 | 31% | 0.83 |
2 | 13 | 42% | 1436 | 34% | |
3 | 4 | 13% | 833 | 20% | |
4 | 3 | 10% | 418 | 10% | |
5 | 2 | 6% | 213 | 5% | |
Risk group | |||||
Low | 8 | 26% | 1066 | 25% | 0.97 |
Intermediate | 17 | 55% | 2392 | 57% | |
High | 6 | 19% | 756 | 18% | |
ADT | |||||
Yes | 7 | 23% | 943 | 22% | 0.98 |
No | 24 | 77% | 3271 | 78% |